

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proline biosynthetic process (GO:0006561) | 8.82979758 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 7.49338957 |
| 3 | transcription from mitochondrial promoter (GO:0006390) | 7.03925065 |
| 4 | proline metabolic process (GO:0006560) | 6.90075175 |
| 5 | fat-soluble vitamin biosynthetic process (GO:0042362) | 6.34452616 |
| 6 | thrombin receptor signaling pathway (GO:0070493) | 6.24038931 |
| 7 | embryonic process involved in female pregnancy (GO:0060136) | 6.19333184 |
| 8 | regulation of protein homooligomerization (GO:0032462) | 5.79173330 |
| 9 | regulation of integrin activation (GO:0033623) | 5.77471422 |
| 10 | positive regulation of protein homooligomerization (GO:0032464) | 5.55814186 |
| 11 | response to pheromone (GO:0019236) | 5.50291607 |
| 12 | regulation of platelet aggregation (GO:0090330) | 5.40926077 |
| 13 | adenosine receptor signaling pathway (GO:0001973) | 5.33392135 |
| 14 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 5.18442377 |
| 15 | regulation of platelet activation (GO:0010543) | 5.12470957 |
| 16 | oxidative demethylation (GO:0070989) | 5.08939194 |
| 17 | cellular response to zinc ion (GO:0071294) | 4.98220839 |
| 18 | replication fork processing (GO:0031297) | 4.94196021 |
| 19 | negative regulation of protein oligomerization (GO:0032460) | 4.84203760 |
| 20 | positive regulation of mast cell activation (GO:0033005) | 4.82780207 |
| 21 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.79292638 |
| 22 | platelet aggregation (GO:0070527) | 4.67656491 |
| 23 | protein neddylation (GO:0045116) | 4.61711750 |
| 24 | cellular response to ATP (GO:0071318) | 4.61104727 |
| 25 | neutrophil activation (GO:0042119) | 4.60552157 |
| 26 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.53130308 |
| 27 | protein localization to endosome (GO:0036010) | 4.49312319 |
| 28 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 4.34987984 |
| 29 | angiogenesis involved in wound healing (GO:0060055) | 4.30126634 |
| 30 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.29169672 |
| 31 | blood coagulation, intrinsic pathway (GO:0007597) | 4.28065791 |
| 32 | granulocyte activation (GO:0036230) | 4.21734452 |
| 33 | lipoxygenase pathway (GO:0019372) | 4.18236952 |
| 34 | embryonic placenta development (GO:0001892) | 4.17777850 |
| 35 | glutamine family amino acid biosynthetic process (GO:0009084) | 4.09527200 |
| 36 | mitochondrial DNA metabolic process (GO:0032042) | 4.05648460 |
| 37 | negative regulation of platelet activation (GO:0010544) | 3.99860345 |
| 38 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.97416861 |
| 39 | intestinal cholesterol absorption (GO:0030299) | 3.96117718 |
| 40 | sulfur amino acid catabolic process (GO:0000098) | 3.93503466 |
| 41 | positive regulation of macrophage differentiation (GO:0045651) | 3.91569803 |
| 42 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.88925845 |
| 43 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.88875641 |
| 44 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.88283010 |
| 45 | establishment of apical/basal cell polarity (GO:0035089) | 3.85184554 |
| 46 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.76957096 |
| 47 | regulation of mast cell degranulation (GO:0043304) | 3.75123400 |
| 48 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.70291456 |
| 49 | GDP-mannose metabolic process (GO:0019673) | 3.69154850 |
| 50 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.67457777 |
| 51 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 3.64587533 |
| 52 | regulation of protein oligomerization (GO:0032459) | 3.63866237 |
| 53 | megakaryocyte development (GO:0035855) | 3.62645873 |
| 54 | regulation of podosome assembly (GO:0071801) | 3.61569411 |
| 55 | negative regulation of JAK-STAT cascade (GO:0046426) | 3.59708012 |
| 56 | regulation of mast cell activation (GO:0033003) | 3.59341562 |
| 57 | purinergic receptor signaling pathway (GO:0035587) | 3.56119321 |
| 58 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.52956690 |
| 59 | positive regulation by host of viral transcription (GO:0043923) | 3.50530568 |
| 60 | negative regulation of norepinephrine secretion (GO:0010700) | 3.50107371 |
| 61 | membrane tubulation (GO:0097320) | 3.47273725 |
| 62 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.47213070 |
| 63 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.43594363 |
| 64 | mitotic G1 DNA damage checkpoint (GO:0031571) | 3.41477844 |
| 65 | positive regulation of mast cell degranulation (GO:0043306) | 3.41200245 |
| 66 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.41200245 |
| 67 | poly(A)+ mRNA export from nucleus (GO:0016973) | 3.40070836 |
| 68 | platelet degranulation (GO:0002576) | 3.39933036 |
| 69 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.39867383 |
| 70 | homotypic cell-cell adhesion (GO:0034109) | 3.38874866 |
| 71 | positive regulation of protein oligomerization (GO:0032461) | 3.32461926 |
| 72 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.31556027 |
| 73 | platelet activation (GO:0030168) | 3.28734459 |
| 74 | leukocyte degranulation (GO:0043299) | 3.28321437 |
| 75 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.27819370 |
| 76 | positive regulation of receptor recycling (GO:0001921) | 3.26655253 |
| 77 | low-density lipoprotein particle remodeling (GO:0034374) | 3.24447361 |
| 78 | myeloid cell activation involved in immune response (GO:0002275) | 3.23186804 |
| 79 | glial cell migration (GO:0008347) | 3.21016231 |
| 80 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.14958448 |
| 81 | negative regulation of Ras GTPase activity (GO:0034261) | 3.14804700 |
| 82 | establishment of monopolar cell polarity (GO:0061162) | 3.13781768 |
| 83 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 3.13781768 |
| 84 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.12328445 |
| 85 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.11878075 |
| 86 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 3.11357035 |
| 87 | negative regulation of cell cycle arrest (GO:0071157) | 3.09878615 |
| 88 | regulation of macrophage chemotaxis (GO:0010758) | 3.09210260 |
| 89 | platelet formation (GO:0030220) | 3.08634695 |
| 90 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 3.08270479 |
| 91 | DNA strand renaturation (GO:0000733) | 3.08025581 |
| 92 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.07330406 |
| 93 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.07330406 |
| 94 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.06935467 |
| 95 | G1 DNA damage checkpoint (GO:0044783) | 3.06176226 |
| 96 | microglial cell activation (GO:0001774) | 3.05403935 |
| 97 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.05244421 |
| 98 | regulation of response to reactive oxygen species (GO:1901031) | 3.05208997 |
| 99 | mitotic G1/S transition checkpoint (GO:0044819) | 3.03164468 |
| 100 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.02878262 |
| 101 | negative regulation of fatty acid metabolic process (GO:0045922) | 3.02361022 |
| 102 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.01628980 |
| 103 | regulation of leukocyte degranulation (GO:0043300) | 3.01363815 |
| 104 | alkaloid metabolic process (GO:0009820) | 3.01024020 |
| 105 | positive regulation of granulocyte differentiation (GO:0030854) | 3.00577536 |
| 106 | negative regulation of response to reactive oxygen species (GO:1901032) | 3.00316710 |
| 107 | positive regulation of blood coagulation (GO:0030194) | 2.99651234 |
| 108 | positive regulation of hemostasis (GO:1900048) | 2.99651234 |
| 109 | response to peptidoglycan (GO:0032494) | 2.98933156 |
| 110 | negative regulation of cell killing (GO:0031342) | 2.98434137 |
| 111 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.98434137 |
| 112 | positive regulation by symbiont of host defense response (GO:0052509) | 2.97957750 |
| 113 | modulation by symbiont of host defense response (GO:0052031) | 2.97957750 |
| 114 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.97957750 |
| 115 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.97957750 |
| 116 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.97957750 |
| 117 | modulation by symbiont of host immune response (GO:0052553) | 2.97957750 |
| 118 | hypotonic response (GO:0006971) | 2.96863544 |
| 119 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.96691104 |
| 120 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.96260305 |
| 121 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.95592711 |
| 122 | heart trabecula formation (GO:0060347) | 2.94147228 |
| 123 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.93819766 |
| 124 | autophagic vacuole fusion (GO:0000046) | 2.93196037 |
| 125 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.93149205 |
| 126 | regulation of vascular permeability (GO:0043114) | 2.91704854 |
| 127 | regulation of translational fidelity (GO:0006450) | 2.90640860 |
| 128 | phagocytosis, engulfment (GO:0006911) | 2.90116012 |
| 129 | regulation of cholesterol homeostasis (GO:2000188) | 2.89817614 |
| 130 | peptide catabolic process (GO:0043171) | 2.88120843 |
| 131 | signal complex assembly (GO:0007172) | 2.86718017 |
| 132 | polyamine biosynthetic process (GO:0006596) | 2.86501371 |
| 133 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.85945829 |
| 134 | cellular extravasation (GO:0045123) | 2.84822611 |
| 135 | positive regulation of developmental pigmentation (GO:0048087) | 2.84206464 |
| 136 | vesicle targeting (GO:0006903) | 2.83350258 |
| 137 | regulation of lipoprotein metabolic process (GO:0050746) | 2.83132309 |
| 138 | vitamin transmembrane transport (GO:0035461) | 2.82709644 |
| 139 | negative regulation of heart rate (GO:0010459) | 2.80538531 |
| 140 | N-glycan processing (GO:0006491) | 2.80293872 |
| 141 | positive regulation of coagulation (GO:0050820) | 2.79807137 |
| 142 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.78895192 |
| 143 | DNA deamination (GO:0045006) | 2.78538329 |
| 144 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.78247889 |
| 145 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.77427845 |
| 146 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.75138830 |
| 147 | positive regulation of B cell mediated immunity (GO:0002714) | 2.75138830 |
| 148 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.75003234 |
| 149 | negative regulation of tumor necrosis factor production (GO:0032720) | 2.74620490 |
| 150 | protein targeting to lysosome (GO:0006622) | 2.74324606 |
| 151 | establishment of protein localization to vacuole (GO:0072666) | 2.74324606 |
| 152 | protein targeting to vacuole (GO:0006623) | 2.74324606 |
| 153 | negative regulation of T cell apoptotic process (GO:0070233) | 2.74219870 |
| 154 | negative regulation of stress fiber assembly (GO:0051497) | 2.73935756 |
| 155 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.73141518 |
| 156 | stress fiber assembly (GO:0043149) | 2.72726695 |
| 157 | face development (GO:0060324) | 2.72613425 |
| 158 | negative regulation of neural precursor cell proliferation (GO:2000178) | 2.72411931 |
| 159 | extracellular fibril organization (GO:0043206) | 2.72409253 |
| 160 | superoxide anion generation (GO:0042554) | 2.71325421 |
| 161 | synaptic vesicle endocytosis (GO:0048488) | 2.71155773 |
| 162 | dosage compensation (GO:0007549) | 2.70834109 |
| 163 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 2.70132539 |
| 164 | membrane invagination (GO:0010324) | 2.68699179 |
| 165 | apoptotic process involved in morphogenesis (GO:0060561) | 2.68564414 |
| 166 | cyclooxygenase pathway (GO:0019371) | 2.68499299 |
| 167 | convergent extension (GO:0060026) | 2.68198529 |
| 168 | negative regulation of interleukin-17 production (GO:0032700) | 2.66979745 |
| 169 | neuromuscular process controlling posture (GO:0050884) | 2.66791999 |
| 170 | activation of Rac GTPase activity (GO:0032863) | 2.66684244 |
| 171 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.65713755 |
| 172 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 2.65609523 |
| 173 | fibril organization (GO:0097435) | 2.64130519 |
| 174 | regulation of cholesterol efflux (GO:0010874) | 2.64006316 |
| 175 | intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631) | 2.63459301 |
| 176 | positive regulation of actin cytoskeleton reorganization (GO:2000251) | 2.60418650 |
| 177 | regulation of mitochondrial depolarization (GO:0051900) | 2.59655995 |
| 178 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.57621347 |
| 179 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.57621347 |
| 180 | protein retention in ER lumen (GO:0006621) | 2.57204260 |
| 181 | positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552) | 2.56335088 |
| 182 | regulation of lamellipodium assembly (GO:0010591) | 2.53423912 |
| 183 | definitive hemopoiesis (GO:0060216) | 2.53318016 |
| 184 | glycogen catabolic process (GO:0005980) | 2.53283134 |
| 185 | positive regulation of lamellipodium assembly (GO:0010592) | 2.52945849 |
| 186 | positive regulation of lipid kinase activity (GO:0090218) | 2.52722744 |
| 187 | regulation of early endosome to late endosome transport (GO:2000641) | 2.48960789 |
| 188 | labyrinthine layer development (GO:0060711) | 2.48498954 |
| 189 | regulation of glomerular filtration (GO:0003093) | 2.48169468 |
| 190 | anatomical structure regression (GO:0060033) | 2.48011250 |
| 191 | retinoic acid receptor signaling pathway (GO:0048384) | 2.47976181 |
| 192 | regulation of phosphatidylinositol 3-kinase activity (GO:0043551) | 2.47355199 |
| 193 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.47169331 |
| 194 | regulation of protein polyubiquitination (GO:1902914) | 2.46287593 |
| 195 | macroautophagy (GO:0016236) | 2.44725997 |
| 196 | fatty acid beta-oxidation (GO:0006635) | 2.43625207 |
| 197 | mitotic cell cycle arrest (GO:0071850) | 2.42355205 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.17692859 |
| 2 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 4.01641961 |
| 3 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 3.97176546 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.61445694 |
| 5 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.56068080 |
| 6 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 3.52325777 |
| 7 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.36039972 |
| 8 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.89701902 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.73165772 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.69765704 |
| 11 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.68231966 |
| 12 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.66986651 |
| 13 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.59485149 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.58360433 |
| 15 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.57694551 |
| 16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.52087641 |
| 17 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.49700736 |
| 18 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.47983972 |
| 19 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.40267996 |
| 20 | GATA2_19941826_ChIP-Seq_K562_Human | 2.35130816 |
| 21 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.32875242 |
| 22 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.26916756 |
| 23 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.23850225 |
| 24 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.23808168 |
| 25 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.22004213 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.21236620 |
| 27 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.19078868 |
| 28 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.17569652 |
| 29 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.16943006 |
| 30 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.15168831 |
| 31 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.14819867 |
| 32 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 2.14368377 |
| 33 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.12946291 |
| 34 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.12506709 |
| 35 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.08293852 |
| 36 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.04016142 |
| 37 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.01578893 |
| 38 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.99463145 |
| 39 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.96548690 |
| 40 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.95074440 |
| 41 | GATA1_22025678_ChIP-Seq_K562_Human | 1.94241593 |
| 42 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.90947851 |
| 43 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.90524416 |
| 44 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.87213497 |
| 45 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.86967546 |
| 46 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.84629550 |
| 47 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.84327746 |
| 48 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.83524666 |
| 49 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.81092392 |
| 50 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.81092392 |
| 51 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.81092392 |
| 52 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.78477707 |
| 53 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.78407010 |
| 54 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.77818633 |
| 55 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.76550359 |
| 56 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.74250476 |
| 57 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.71118169 |
| 58 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.69779609 |
| 59 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.69209962 |
| 60 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.67855129 |
| 61 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.67702135 |
| 62 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.67112270 |
| 63 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.66933648 |
| 64 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.64196329 |
| 65 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.60657373 |
| 66 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.60652957 |
| 67 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.60065949 |
| 68 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.59577300 |
| 69 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.56598541 |
| 70 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.55526122 |
| 71 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.54892037 |
| 72 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.51549979 |
| 73 | KDM2B_26808549_Chip-Seq_K562_Human | 1.50875052 |
| 74 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.48053068 |
| 75 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.47627879 |
| 76 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.44319790 |
| 77 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.42900015 |
| 78 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.42290297 |
| 79 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.41668128 |
| 80 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.39007500 |
| 81 | * POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.36044967 |
| 82 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35193422 |
| 83 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.34931444 |
| 84 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.34676261 |
| 85 | MYB_26560356_Chip-Seq_TH2_Human | 1.33460178 |
| 86 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.32540353 |
| 87 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.31478695 |
| 88 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.30487079 |
| 89 | * ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.28303461 |
| 90 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.26988564 |
| 91 | * SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.26705015 |
| 92 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.26429873 |
| 93 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.25478903 |
| 94 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24772722 |
| 95 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.22014989 |
| 96 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.20708652 |
| 97 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20679469 |
| 98 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.20145028 |
| 99 | MYC_22102868_ChIP-Seq_BL_Human | 1.20138421 |
| 100 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.19661130 |
| 101 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18787480 |
| 102 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17808624 |
| 103 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17807761 |
| 104 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15503519 |
| 105 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15459797 |
| 106 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.14699484 |
| 107 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.14218205 |
| 108 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.13619048 |
| 109 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.13462362 |
| 110 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.13361669 |
| 111 | MYB_26560356_Chip-Seq_TH1_Human | 1.13020392 |
| 112 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12900554 |
| 113 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.12746463 |
| 114 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.12524655 |
| 115 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.12198450 |
| 116 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.11551639 |
| 117 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.11292024 |
| 118 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.10051129 |
| 119 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.09935056 |
| 120 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09454562 |
| 121 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.09332040 |
| 122 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.07965449 |
| 123 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.07435169 |
| 124 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.07116380 |
| 125 | MAF_26560356_Chip-Seq_TH1_Human | 1.06850982 |
| 126 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06688764 |
| 127 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.06455586 |
| 128 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06411532 |
| 129 | * ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.06136805 |
| 130 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.05486495 |
| 131 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05251574 |
| 132 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.04938291 |
| 133 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.04918904 |
| 134 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04844486 |
| 135 | * SPI1_20517297_ChIP-Seq_HL60_Human | 1.04719358 |
| 136 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04639059 |
| 137 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.04031024 |
| 138 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03774823 |
| 139 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.02822108 |
| 140 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.02735340 |
| 141 | UTX_26944678_Chip-Seq_JUKART_Human | 1.02491646 |
| 142 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.01319522 |
| 143 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.01147427 |
| 144 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.00581226 |
| 145 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.00496519 |
| 146 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.00387021 |
| 147 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.99734334 |
| 148 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.99324585 |
| 149 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.98752012 |
| 150 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.98379135 |
| 151 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.98326655 |
| 152 | SPI1_23127762_ChIP-Seq_K562_Human | 0.97840152 |
| 153 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.97110519 |
| 154 | MAF_26560356_Chip-Seq_TH2_Human | 0.96527937 |
| 155 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.96125784 |
| 156 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.95972133 |
| 157 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.95615472 |
| 158 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.95615472 |
| 159 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.95348816 |
| 160 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.95114305 |
| 161 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.93651762 |
| 162 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.92614707 |
| 163 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90602864 |
| 164 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90068587 |
| 165 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.88542606 |
| 166 | GATA3_26560356_Chip-Seq_TH2_Human | 0.87747436 |
| 167 | * CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86182351 |
| 168 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.85877937 |
| 169 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82843137 |
| 170 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81935565 |
| 171 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81053924 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008004_abnormal_stomach_pH | 4.50161090 |
| 2 | MP0003724_increased_susceptibility_to | 4.34335028 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.97513687 |
| 4 | MP0009278_abnormal_bone_marrow | 3.70404313 |
| 5 | MP0004233_abnormal_muscle_weight | 3.64468301 |
| 6 | MP0008057_abnormal_DNA_replication | 3.36089560 |
| 7 | MP0005171_absent_coat_pigmentation | 3.34450971 |
| 8 | MP0000465_gastrointestinal_hemorrhage | 3.07904449 |
| 9 | MP0004510_myositis | 2.93849766 |
| 10 | MP0001835_abnormal_antigen_presentation | 2.87308873 |
| 11 | MP0005365_abnormal_bile_salt | 2.82899000 |
| 12 | MP0003172_abnormal_lysosome_physiology | 2.79157730 |
| 13 | MP0005085_abnormal_gallbladder_physiolo | 2.67247774 |
| 14 | MP0002009_preneoplasia | 2.59461017 |
| 15 | MP0003436_decreased_susceptibility_to | 2.58006534 |
| 16 | MP0009840_abnormal_foam_cell | 2.16420350 |
| 17 | MP0002148_abnormal_hypersensitivity_rea | 2.14691233 |
| 18 | MP0005000_abnormal_immune_tolerance | 2.02903935 |
| 19 | MP0005167_abnormal_blood-brain_barrier | 2.01479001 |
| 20 | MP0004130_abnormal_muscle_cell | 1.99270876 |
| 21 | MP0005670_abnormal_white_adipose | 1.96037688 |
| 22 | MP0002269_muscular_atrophy | 1.93650864 |
| 23 | MP0003828_pulmonary_edema | 1.90731211 |
| 24 | MP0003806_abnormal_nucleotide_metabolis | 1.88464800 |
| 25 | MP0005671_abnormal_response_to | 1.85295368 |
| 26 | MP0002419_abnormal_innate_immunity | 1.84979003 |
| 27 | MP0003300_gastrointestinal_ulcer | 1.83624228 |
| 28 | MP0010155_abnormal_intestine_physiology | 1.80693702 |
| 29 | MP0004019_abnormal_vitamin_homeostasis | 1.79747199 |
| 30 | MP0003453_abnormal_keratinocyte_physiol | 1.79488665 |
| 31 | MP0002723_abnormal_immune_serum | 1.75292618 |
| 32 | MP0001800_abnormal_humoral_immune | 1.73902939 |
| 33 | MP0002452_abnormal_antigen_presenting | 1.72524544 |
| 34 | MP0005330_cardiomyopathy | 1.70928232 |
| 35 | MP0010630_abnormal_cardiac_muscle | 1.70126195 |
| 36 | MP0004947_skin_inflammation | 1.69951574 |
| 37 | MP0001851_eye_inflammation | 1.69319979 |
| 38 | MP0001533_abnormal_skeleton_physiology | 1.68787166 |
| 39 | MP0006082_CNS_inflammation | 1.65980028 |
| 40 | MP0002398_abnormal_bone_marrow | 1.64949314 |
| 41 | MP0001873_stomach_inflammation | 1.62489272 |
| 42 | MP0001790_abnormal_immune_system | 1.59194629 |
| 43 | MP0005387_immune_system_phenotype | 1.59194629 |
| 44 | MP0005025_abnormal_response_to | 1.59124084 |
| 45 | MP0005076_abnormal_cell_differentiation | 1.58668881 |
| 46 | MP0000858_altered_metastatic_potential | 1.53595020 |
| 47 | MP0002420_abnormal_adaptive_immunity | 1.52681830 |
| 48 | MP0000751_myopathy | 1.51612416 |
| 49 | MP0001819_abnormal_immune_cell | 1.50846661 |
| 50 | MP0003567_abnormal_fetal_cardiomyocyte | 1.48617795 |
| 51 | MP0005397_hematopoietic_system_phenotyp | 1.47514434 |
| 52 | MP0001545_abnormal_hematopoietic_system | 1.47514434 |
| 53 | MP0005360_urolithiasis | 1.46206655 |
| 54 | MP0008995_early_reproductive_senescence | 1.44566003 |
| 55 | MP0000579_abnormal_nail_morphology | 1.43672538 |
| 56 | MP0009764_decreased_sensitivity_to | 1.43132707 |
| 57 | MP0002139_abnormal_hepatobiliary_system | 1.42756458 |
| 58 | MP0002166_altered_tumor_susceptibility | 1.39559174 |
| 59 | MP0005083_abnormal_biliary_tract | 1.39199258 |
| 60 | MP0010030_abnormal_orbit_morphology | 1.39158738 |
| 61 | MP0003191_abnormal_cellular_cholesterol | 1.38538038 |
| 62 | MP0006072_abnormal_retinal_apoptosis | 1.38494918 |
| 63 | MP0003075_altered_response_to | 1.37386711 |
| 64 | MP0000230_abnormal_systemic_arterial | 1.35849812 |
| 65 | MP0000685_abnormal_immune_system | 1.35567954 |
| 66 | MP0006138_congestive_heart_failure | 1.34667191 |
| 67 | MP0000470_abnormal_stomach_morphology | 1.34624531 |
| 68 | MP0001845_abnormal_inflammatory_respons | 1.32279426 |
| 69 | MP0008260_abnormal_autophagy | 1.32177695 |
| 70 | MP0002132_abnormal_respiratory_system | 1.30959814 |
| 71 | MP0009115_abnormal_fat_cell | 1.30323558 |
| 72 | MP0002837_dystrophic_cardiac_calcinosis | 1.30066718 |
| 73 | MP0009785_altered_susceptibility_to | 1.29138665 |
| 74 | MP0001663_abnormal_digestive_system | 1.28798945 |
| 75 | MP0003137_abnormal_impulse_conducting | 1.28666769 |
| 76 | MP0002998_abnormal_bone_remodeling | 1.28213526 |
| 77 | MP0004087_abnormal_muscle_fiber | 1.27757972 |
| 78 | MP0000689_abnormal_spleen_morphology | 1.27733988 |
| 79 | MP0000249_abnormal_blood_vessel | 1.26162887 |
| 80 | MP0003656_abnormal_erythrocyte_physiolo | 1.25888144 |
| 81 | MP0002429_abnormal_blood_cell | 1.25411727 |
| 82 | MP0000716_abnormal_immune_system | 1.24751385 |
| 83 | MP0010329_abnormal_lipoprotein_level | 1.24505505 |
| 84 | MP0004084_abnormal_cardiac_muscle | 1.22763133 |
| 85 | MP0002118_abnormal_lipid_homeostasis | 1.18445350 |
| 86 | MP0003283_abnormal_digestive_organ | 1.18199912 |
| 87 | MP0009763_increased_sensitivity_to | 1.17999973 |
| 88 | MP0002722_abnormal_immune_system | 1.17572215 |
| 89 | MP0003638_abnormal_response/metabolism_ | 1.16803336 |
| 90 | MP0000371_diluted_coat_color | 1.16094879 |
| 91 | MP0003045_fibrosis | 1.14544021 |
| 92 | MP0009333_abnormal_splenocyte_physiolog | 1.14187891 |
| 93 | MP0002108_abnormal_muscle_morphology | 1.13841033 |
| 94 | MP0000639_abnormal_adrenal_gland | 1.12760993 |
| 95 | MP0005165_increased_susceptibility_to | 1.08223060 |
| 96 | MP0005409_darkened_coat_color | 1.07489401 |
| 97 | MP0000015_abnormal_ear_pigmentation | 1.05495003 |
| 98 | MP0005410_abnormal_fertilization | 1.05229015 |
| 99 | MP0003705_abnormal_hypodermis_morpholog | 1.05011543 |
| 100 | MP0002877_abnormal_melanocyte_morpholog | 1.04893353 |
| 101 | MP0003091_abnormal_cell_migration | 1.04465095 |
| 102 | MP0006054_spinal_hemorrhage | 1.03440858 |
| 103 | MP0003763_abnormal_thymus_physiology | 1.03012485 |
| 104 | MP0001879_abnormal_lymphatic_vessel | 1.02525843 |
| 105 | MP0002971_abnormal_brown_adipose | 1.02327419 |
| 106 | MP0002106_abnormal_muscle_physiology | 1.01187515 |
| 107 | MP0005369_muscle_phenotype | 0.98049180 |
| 108 | MP0003690_abnormal_glial_cell | 0.97866984 |
| 109 | MP0008775_abnormal_heart_ventricle | 0.97058521 |
| 110 | MP0005332_abnormal_amino_acid | 0.96879701 |
| 111 | MP0002796_impaired_skin_barrier | 0.96829470 |
| 112 | MP0004883_abnormal_blood_vessel | 0.96761450 |
| 113 | MP0000747_muscle_weakness | 0.96645156 |
| 114 | MP0004036_abnormal_muscle_relaxation | 0.95511991 |
| 115 | MP0005084_abnormal_gallbladder_morpholo | 0.94574146 |
| 116 | MP0005023_abnormal_wound_healing | 0.93286917 |
| 117 | MP0000609_abnormal_liver_physiology | 0.93192726 |
| 118 | MP0003866_abnormal_defecation | 0.92703664 |
| 119 | MP0003879_abnormal_hair_cell | 0.91883708 |
| 120 | MP0005464_abnormal_platelet_physiology | 0.91772834 |
| 121 | MP0004185_abnormal_adipocyte_glucose | 0.90482515 |
| 122 | MP0002086_abnormal_extraembryonic_tissu | 0.89962923 |
| 123 | MP0002736_abnormal_nociception_after | 0.89581218 |
| 124 | MP0005666_abnormal_adipose_tissue | 0.88299976 |
| 125 | MP0003448_altered_tumor_morphology | 0.88233079 |
| 126 | MP0005310_abnormal_salivary_gland | 0.87184472 |
| 127 | MP0003633_abnormal_nervous_system | 0.86734979 |
| 128 | MP0001666_abnormal_nutrient_absorption | 0.86579049 |
| 129 | MP0009765_abnormal_xenobiotic_induced | 0.85261722 |
| 130 | MP0005266_abnormal_metabolism | 0.84518906 |
| 131 | MP0001324_abnormal_eye_pigmentation | 0.83272397 |
| 132 | MP0002006_tumorigenesis | 0.82945871 |
| 133 | MP0003183_abnormal_peptide_metabolism | 0.82537246 |
| 134 | MP0000703_abnormal_thymus_morphology | 0.81654400 |
| 135 | MP0001544_abnormal_cardiovascular_syste | 0.81604636 |
| 136 | MP0005385_cardiovascular_system_phenoty | 0.81604636 |
| 137 | MP0003890_abnormal_embryonic-extraembry | 0.81462322 |
| 138 | MP0000759_abnormal_skeletal_muscle | 0.81031738 |
| 139 | MP0004808_abnormal_hematopoietic_stem | 0.80089315 |
| 140 | MP0005319_abnormal_enzyme/_coenzyme | 0.79717837 |
| 141 | MP0003566_abnormal_cell_adhesion | 0.79235169 |
| 142 | MP0008469_abnormal_protein_level | 0.76908294 |
| 143 | MP0004484_altered_response_of | 0.76074937 |
| 144 | MP0005381_digestive/alimentary_phenotyp | 0.75922644 |
| 145 | MP0009642_abnormal_blood_homeostasis | 0.75346969 |
| 146 | MP0005174_abnormal_tail_pigmentation | 0.74260624 |
| 147 | MP0003943_abnormal_hepatobiliary_system | 0.73269334 |
| 148 | MP0005164_abnormal_response_to | 0.72937979 |
| 149 | MP0001915_intracranial_hemorrhage | 0.72899120 |
| 150 | MP0003634_abnormal_glial_cell | 0.72704343 |
| 151 | MP0002405_respiratory_system_inflammati | 0.72704014 |
| 152 | MP0005075_abnormal_melanosome_morpholog | 0.72396604 |
| 153 | MP0002332_abnormal_exercise_endurance | 0.71893503 |
| 154 | MP0000490_abnormal_crypts_of | 0.70814334 |
| 155 | MP0000343_altered_response_to | 0.70383269 |
| 156 | MP0001765_abnormal_ion_homeostasis | 0.68844127 |
| 157 | MP0003795_abnormal_bone_structure | 0.68237976 |
| 158 | MP0001784_abnormal_fluid_regulation | 0.67787102 |
| 159 | MP0005375_adipose_tissue_phenotype | 0.67730044 |
| 160 | MP0008874_decreased_physiological_sensi | 0.67442036 |
| 161 | MP0004133_heterotaxia | 0.66982694 |
| 162 | MP0008872_abnormal_physiological_respon | 0.66794112 |
| 163 | MP0002060_abnormal_skin_morphology | 0.65939760 |
| 164 | MP0004264_abnormal_extraembryonic_tissu | 0.65546720 |
| 165 | MP0008875_abnormal_xenobiotic_pharmacok | 0.65182716 |
| 166 | MP0005166_decreased_susceptibility_to | 0.65135221 |
| 167 | MP0000266_abnormal_heart_morphology | 0.63831206 |
| 168 | MP0003303_peritoneal_inflammation | 0.63327351 |
| 169 | MP0003631_nervous_system_phenotype | 0.62072638 |
| 170 | MP0000598_abnormal_liver_morphology | 0.61637557 |
| 171 | MP0009643_abnormal_urine_homeostasis | 0.61308170 |
| 172 | MP0005334_abnormal_fat_pad | 0.60724152 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased mean platelet volume (HP:0011877) | 9.39829134 |
| 2 | Menorrhagia (HP:0000132) | 9.12542391 |
| 3 | Abnormal platelet volume (HP:0011876) | 9.04879375 |
| 4 | Purpura (HP:0000979) | 8.31836083 |
| 5 | Epistaxis (HP:0000421) | 7.27510750 |
| 6 | Gingival bleeding (HP:0000225) | 6.34225751 |
| 7 | Annular pancreas (HP:0001734) | 5.54696446 |
| 8 | Abnormal platelet function (HP:0011869) | 5.33017205 |
| 9 | Impaired platelet aggregation (HP:0003540) | 5.33017205 |
| 10 | Turricephaly (HP:0000262) | 5.17126396 |
| 11 | Spontaneous hematomas (HP:0007420) | 4.80528505 |
| 12 | Pustule (HP:0200039) | 4.63397866 |
| 13 | Hyperlipoproteinemia (HP:0010980) | 4.57291145 |
| 14 | Pancreatic islet-cell hyperplasia (HP:0004510) | 4.51119180 |
| 15 | Dysostosis multiplex (HP:0000943) | 4.50911558 |
| 16 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.37306625 |
| 17 | Mucopolysacchariduria (HP:0008155) | 4.37306625 |
| 18 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.09085239 |
| 19 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.09085239 |
| 20 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.09085239 |
| 21 | Ulnar bowing (HP:0003031) | 4.01702004 |
| 22 | Alopecia of scalp (HP:0002293) | 3.91619676 |
| 23 | Dyschromatopsia (HP:0007641) | 3.87499123 |
| 24 | Asymmetric septal hypertrophy (HP:0001670) | 3.75947108 |
| 25 | Abnormality of macrophages (HP:0004311) | 3.73721710 |
| 26 | Conjunctival telangiectasia (HP:0000524) | 3.62659086 |
| 27 | Increased CSF protein (HP:0002922) | 3.51645813 |
| 28 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.49512140 |
| 29 | Abnormality of the aortic arch (HP:0012303) | 3.47914974 |
| 30 | Increased IgM level (HP:0003496) | 3.47020301 |
| 31 | Poikilocytosis (HP:0004447) | 3.46379323 |
| 32 | Bruising susceptibility (HP:0000978) | 3.38318276 |
| 33 | Abnormality of the common coagulation pathway (HP:0010990) | 3.35972545 |
| 34 | Acanthocytosis (HP:0001927) | 3.31074713 |
| 35 | Rib fusion (HP:0000902) | 3.29995693 |
| 36 | Growth hormone excess (HP:0000845) | 3.28178603 |
| 37 | Hypochromic microcytic anemia (HP:0004840) | 3.25272418 |
| 38 | Exercise-induced myalgia (HP:0003738) | 3.20013544 |
| 39 | Facial hemangioma (HP:0000329) | 3.10750646 |
| 40 | Rectal fistula (HP:0100590) | 3.09843979 |
| 41 | Rectovaginal fistula (HP:0000143) | 3.09843979 |
| 42 | Male infertility (HP:0003251) | 3.08087614 |
| 43 | Large for gestational age (HP:0001520) | 3.06043902 |
| 44 | Vaginal fistula (HP:0004320) | 3.03997744 |
| 45 | Coronal craniosynostosis (HP:0004440) | 3.03362358 |
| 46 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.03046929 |
| 47 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.03046929 |
| 48 | Poikiloderma (HP:0001029) | 3.01612156 |
| 49 | Polycythemia (HP:0001901) | 2.97608400 |
| 50 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.94798158 |
| 51 | Stomatitis (HP:0010280) | 2.93815810 |
| 52 | Intestinal fistula (HP:0100819) | 2.89848395 |
| 53 | Paralysis (HP:0003470) | 2.86146076 |
| 54 | Increased density of long bones (HP:0006392) | 2.85288495 |
| 55 | Cerebral aneurysm (HP:0004944) | 2.83406535 |
| 56 | Colitis (HP:0002583) | 2.82989870 |
| 57 | Recurrent bacterial skin infections (HP:0005406) | 2.82573218 |
| 58 | Recurrent abscess formation (HP:0002722) | 2.80520705 |
| 59 | Hepatosplenomegaly (HP:0001433) | 2.77026702 |
| 60 | Clumsiness (HP:0002312) | 2.73852306 |
| 61 | Ketoacidosis (HP:0001993) | 2.69659815 |
| 62 | Chronic obstructive pulmonary disease (HP:0006510) | 2.67379804 |
| 63 | Obstructive lung disease (HP:0006536) | 2.67379804 |
| 64 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.64409119 |
| 65 | Premature skin wrinkling (HP:0100678) | 2.63927465 |
| 66 | Concave nail (HP:0001598) | 2.58545348 |
| 67 | Intestinal atresia (HP:0011100) | 2.58210323 |
| 68 | Short humerus (HP:0005792) | 2.50865724 |
| 69 | Anteriorly placed anus (HP:0001545) | 2.49377239 |
| 70 | Abnormality of iron homeostasis (HP:0011031) | 2.49042123 |
| 71 | Myocardial infarction (HP:0001658) | 2.45571101 |
| 72 | Abnormal pupillary function (HP:0007686) | 2.45115367 |
| 73 | Abnormality of male internal genitalia (HP:0000022) | 2.43387096 |
| 74 | Abnormality of the periventricular white matter (HP:0002518) | 2.41445536 |
| 75 | Lower limb hyperreflexia (HP:0002395) | 2.39884860 |
| 76 | Arterial thrombosis (HP:0004420) | 2.38735621 |
| 77 | Joint stiffness (HP:0001387) | 2.38006934 |
| 78 | Muscle fibrillation (HP:0010546) | 2.34603347 |
| 79 | Hypokinesia (HP:0002375) | 2.34077835 |
| 80 | Hypoglycemic coma (HP:0001325) | 2.33388052 |
| 81 | Tongue fasciculations (HP:0001308) | 2.31168036 |
| 82 | Abnormal hemoglobin (HP:0011902) | 2.30895441 |
| 83 | Congenital hip dislocation (HP:0001374) | 2.30595395 |
| 84 | Alacrima (HP:0000522) | 2.30579930 |
| 85 | Generalized amyotrophy (HP:0003700) | 2.30475507 |
| 86 | Encephalitis (HP:0002383) | 2.26601249 |
| 87 | Joint swelling (HP:0001386) | 2.24932770 |
| 88 | Increased serum ferritin (HP:0003281) | 2.22750297 |
| 89 | Ketosis (HP:0001946) | 2.20425011 |
| 90 | Albinism (HP:0001022) | 2.19592940 |
| 91 | Orthostatic hypotension (HP:0001278) | 2.16977788 |
| 92 | Vertebral hypoplasia (HP:0008417) | 2.14057161 |
| 93 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.14057161 |
| 94 | Tetany (HP:0001281) | 2.13808830 |
| 95 | Diaphragmatic weakness (HP:0009113) | 2.13040382 |
| 96 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.11602820 |
| 97 | Hypoglycemic seizures (HP:0002173) | 2.07210113 |
| 98 | Episodic fever (HP:0001954) | 2.07126454 |
| 99 | Bowed forearm bones (HP:0003956) | 2.06359033 |
| 100 | Bowing of the arm (HP:0006488) | 2.06359033 |
| 101 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.05840669 |
| 102 | Increased circulating renin level (HP:0000848) | 2.04945896 |
| 103 | Hypotrichosis (HP:0001006) | 2.03741785 |
| 104 | Chest pain (HP:0100749) | 2.01248596 |
| 105 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.01195125 |
| 106 | Prolonged bleeding time (HP:0003010) | 10.5271345 |
| 107 | Short chin (HP:0000331) | 1.99899730 |
| 108 | Myoglobinuria (HP:0002913) | 1.98664347 |
| 109 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.93470365 |
| 110 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.91740371 |
| 111 | Abnormality of lateral ventricle (HP:0030047) | 1.91486542 |
| 112 | Thrombocytosis (HP:0001894) | 1.91080860 |
| 113 | Vacuolated lymphocytes (HP:0001922) | 1.90639829 |
| 114 | Exercise-induced muscle cramps (HP:0003710) | 1.90398112 |
| 115 | Autoimmune thrombocytopenia (HP:0001973) | 1.89948308 |
| 116 | Dysautonomia (HP:0002459) | 1.88950674 |
| 117 | Decreased central vision (HP:0007663) | 1.88532482 |
| 118 | Inflammation of the large intestine (HP:0002037) | 1.88011889 |
| 119 | Choanal stenosis (HP:0000452) | 1.87665957 |
| 120 | IgA deficiency (HP:0002720) | 1.87332966 |
| 121 | Tinnitus (HP:0000360) | 1.86152800 |
| 122 | Hypochromic anemia (HP:0001931) | 1.86085031 |
| 123 | Myositis (HP:0100614) | 1.85912236 |
| 124 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.85101266 |
| 125 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.84766894 |
| 126 | Increased cerebral lipofuscin (HP:0011813) | 1.84439320 |
| 127 | Hypercortisolism (HP:0001578) | 1.81774182 |
| 128 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.81436475 |
| 129 | Aplasia of the musculature (HP:0100854) | 1.81432578 |
| 130 | Basal ganglia calcification (HP:0002135) | 1.81209856 |
| 131 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.81140101 |
| 132 | Distal lower limb amyotrophy (HP:0008944) | 1.79864230 |
| 133 | Xanthomatosis (HP:0000991) | 1.79507510 |
| 134 | Split hand (HP:0001171) | 1.79078706 |
| 135 | Orchitis (HP:0100796) | 1.78721508 |
| 136 | Abnormality of T cell physiology (HP:0011840) | 1.77553844 |
| 137 | Recurrent fungal infections (HP:0002841) | 1.77499164 |
| 138 | Retrobulbar optic neuritis (HP:0100654) | 1.76443757 |
| 139 | Optic neuritis (HP:0100653) | 1.76443757 |
| 140 | Joint hemorrhage (HP:0005261) | 1.75977255 |
| 141 | Acute hepatic failure (HP:0006554) | 1.75892644 |
| 142 | Hemorrhage of the eye (HP:0011885) | 1.74258450 |
| 143 | Hamartoma (HP:0010566) | 1.74252629 |
| 144 | Petechiae (HP:0000967) | 1.74166309 |
| 145 | Hypoplastic ischia (HP:0003175) | 1.74135737 |
| 146 | Intrahepatic cholestasis (HP:0001406) | 1.73841869 |
| 147 | Gastrointestinal inflammation (HP:0004386) | 1.73513370 |
| 148 | Coarse hair (HP:0002208) | 1.73496351 |
| 149 | Eczematoid dermatitis (HP:0000976) | 1.72320368 |
| 150 | Autoimmune hemolytic anemia (HP:0001890) | 1.71557753 |
| 151 | Upper limb muscle weakness (HP:0003484) | 1.71390422 |
| 152 | Peripheral demyelination (HP:0011096) | 1.70848146 |
| 153 | Vertigo (HP:0002321) | 1.70775486 |
| 154 | Leukocytosis (HP:0001974) | 1.70721805 |
| 155 | Nausea (HP:0002018) | 1.69498621 |
| 156 | Systemic lupus erythematosus (HP:0002725) | 1.69257818 |
| 157 | Mucosal telangiectasiae (HP:0100579) | 1.68901929 |
| 158 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.67437111 |
| 159 | Capillary hemangiomas (HP:0005306) | 1.65905840 |
| 160 | Hypophosphatemic rickets (HP:0004912) | 1.61541358 |
| 161 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.61374439 |
| 162 | Gastrointestinal infarctions (HP:0005244) | 1.61208807 |
| 163 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.60827592 |
| 164 | Recurrent skin infections (HP:0001581) | 1.59444607 |
| 165 | Ventricular fibrillation (HP:0001663) | 1.58762285 |
| 166 | Cerebral ischemia (HP:0002637) | 1.57741061 |
| 167 | Vasculitis (HP:0002633) | 1.57226358 |
| 168 | Hypertriglyceridemia (HP:0002155) | 1.56791679 |
| 169 | Hyperthyroidism (HP:0000836) | 1.56039711 |
| 170 | Granulocytopenia (HP:0001913) | 1.55519300 |
| 171 | Thrombophlebitis (HP:0004418) | 1.55153010 |
| 172 | Pulmonary embolism (HP:0002204) | 1.54868950 |
| 173 | Amaurosis fugax (HP:0100576) | 1.53084087 |
| 174 | Meningitis (HP:0001287) | 1.52745484 |
| 175 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.50723131 |
| 176 | Spontaneous abortion (HP:0005268) | 1.50516798 |
| 177 | Abnormal auditory evoked potentials (HP:0006958) | 1.50412454 |
| 178 | Testicular neoplasm (HP:0010788) | 1.49606844 |
| 179 | Gingivitis (HP:0000230) | 1.49452415 |
| 180 | Papillary thyroid carcinoma (HP:0002895) | 1.48907601 |
| 181 | Arthralgia (HP:0002829) | 1.48465660 |
| 182 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.45038551 |
| 183 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.45038551 |
| 184 | Abnormality of glycolipid metabolism (HP:0010969) | 1.45038551 |
| 185 | Abnormality of the prostate (HP:0008775) | 1.44081231 |
| 186 | T lymphocytopenia (HP:0005403) | 1.42914556 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 8.13320342 |
| 2 | ICK | 5.25448139 |
| 3 | MAPK15 | 4.01959414 |
| 4 | MST4 | 3.64223606 |
| 5 | MAP3K6 | 3.57422470 |
| 6 | DDR2 | 3.49243271 |
| 7 | PINK1 | 3.03278509 |
| 8 | BTK | 2.93032085 |
| 9 | MYLK | 2.60596592 |
| 10 | FGR | 2.46439966 |
| 11 | MAP3K11 | 2.34630400 |
| 12 | ZAP70 | 2.33891179 |
| 13 | SYK | 2.32322300 |
| 14 | CSF1R | 2.29958926 |
| 15 | GRK6 | 2.24476536 |
| 16 | MAP2K3 | 2.21406538 |
| 17 | PTK2B | 2.17986318 |
| 18 | TRPM7 | 2.17604159 |
| 19 | CAMK1D | 2.13950953 |
| 20 | EIF2AK1 | 2.11231414 |
| 21 | MATK | 2.01211277 |
| 22 | BMPR2 | 1.93084267 |
| 23 | CSK | 1.93054498 |
| 24 | TYRO3 | 1.86873682 |
| 25 | UHMK1 | 1.84944306 |
| 26 | PIK3CG | 1.77943308 |
| 27 | PRKD2 | 1.74703793 |
| 28 | PDGFRA | 1.73484358 |
| 29 | FES | 1.73253800 |
| 30 | DYRK1B | 1.67090710 |
| 31 | CAMK1G | 1.65422926 |
| 32 | HCK | 1.65129548 |
| 33 | GRK5 | 1.57942923 |
| 34 | IRAK3 | 1.50773288 |
| 35 | IKBKB | 1.47525171 |
| 36 | PHKG1 | 1.43415957 |
| 37 | PHKG2 | 1.43415957 |
| 38 | DAPK1 | 1.41457005 |
| 39 | TEC | 1.32807573 |
| 40 | ACVR1B | 1.32379139 |
| 41 | ILK | 1.31829239 |
| 42 | JAK3 | 1.25100411 |
| 43 | GRK1 | 1.23536208 |
| 44 | MAP3K3 | 1.23262937 |
| 45 | TESK2 | 1.16889578 |
| 46 | IRAK4 | 1.15567813 |
| 47 | MARK3 | 1.15366123 |
| 48 | TRIB3 | 1.15052181 |
| 49 | YES1 | 1.14655942 |
| 50 | PIM2 | 1.10908947 |
| 51 | TAOK2 | 1.09030412 |
| 52 | STK24 | 1.08940098 |
| 53 | TTN | 1.08138625 |
| 54 | SIK3 | 1.06496180 |
| 55 | STK3 | 1.05533611 |
| 56 | TAOK3 | 1.04054786 |
| 57 | MAPK11 | 1.01734778 |
| 58 | DMPK | 1.01620477 |
| 59 | TAOK1 | 1.01344249 |
| 60 | CDK6 | 1.00596794 |
| 61 | RPS6KL1 | 0.99904307 |
| 62 | RPS6KC1 | 0.99904307 |
| 63 | PAK1 | 0.99267163 |
| 64 | PDK1 | 0.98207474 |
| 65 | ADRBK2 | 0.98138243 |
| 66 | GSK3A | 0.96046191 |
| 67 | IRAK1 | 0.96024319 |
| 68 | ITK | 0.94347879 |
| 69 | CDC42BPA | 0.92780841 |
| 70 | ARAF | 0.90581354 |
| 71 | RPS6KA6 | 0.89878669 |
| 72 | MAPKAPK3 | 0.87422816 |
| 73 | * BMX | 0.86587601 |
| 74 | TYK2 | 0.86522086 |
| 75 | MAP3K5 | 0.86153952 |
| 76 | MAP3K14 | 0.85991706 |
| 77 | RIPK1 | 0.85680018 |
| 78 | AKT3 | 0.84413865 |
| 79 | PRKAA1 | 0.83284710 |
| 80 | INSRR | 0.82591352 |
| 81 | IKBKE | 0.78449066 |
| 82 | HIPK2 | 0.77898717 |
| 83 | TXK | 0.77752240 |
| 84 | IRAK2 | 0.77439898 |
| 85 | DAPK3 | 0.76760433 |
| 86 | MAP3K1 | 0.75086341 |
| 87 | PRKAA2 | 0.73580191 |
| 88 | LCK | 0.72407393 |
| 89 | CAMKK2 | 0.72286897 |
| 90 | PIM1 | 0.71951627 |
| 91 | STK4 | 0.69958239 |
| 92 | EPHB1 | 0.69739089 |
| 93 | MAP4K1 | 0.68732918 |
| 94 | ADRBK1 | 0.68717327 |
| 95 | LMTK2 | 0.67849155 |
| 96 | RET | 0.67532756 |
| 97 | MTOR | 0.66806701 |
| 98 | EGFR | 0.66224269 |
| 99 | CDK7 | 0.64600096 |
| 100 | MAPK12 | 0.58668299 |
| 101 | BCKDK | 0.58542119 |
| 102 | LATS2 | 0.58509952 |
| 103 | PRKD1 | 0.58148118 |
| 104 | PKN2 | 0.55759717 |
| 105 | RPS6KA1 | 0.48928967 |
| 106 | ERBB2 | 0.47696358 |
| 107 | FYN | 0.47355964 |
| 108 | DAPK2 | 0.46496268 |
| 109 | ERN1 | 0.46209962 |
| 110 | SGK1 | 0.41618762 |
| 111 | CDK12 | 0.41367743 |
| 112 | CAMK2D | 0.39464870 |
| 113 | EPHA3 | 0.38700035 |
| 114 | PDGFRB | 0.38283795 |
| 115 | MAP3K10 | 0.37957856 |
| 116 | LRRK2 | 0.37261288 |
| 117 | CAMK4 | 0.37223228 |
| 118 | PKN1 | 0.37108187 |
| 119 | MAP2K1 | 0.34267830 |
| 120 | NEK9 | 0.33721581 |
| 121 | CAMK2G | 0.33382462 |
| 122 | CAMK2B | 0.32245528 |
| 123 | SIK1 | 0.31709458 |
| 124 | PRKCQ | 0.31655588 |
| 125 | TLK1 | 0.31045553 |
| 126 | PRKCD | 0.30998951 |
| 127 | TGFBR2 | 0.30568991 |
| 128 | PDPK1 | 0.30291801 |
| 129 | LYN | 0.30084611 |
| 130 | PTK2 | 0.29542736 |
| 131 | SGK3 | 0.29338398 |
| 132 | GRK7 | 0.29122203 |
| 133 | MAPK10 | 0.28910902 |
| 134 | MAP2K2 | 0.28871669 |
| 135 | JAK2 | 0.28763666 |
| 136 | PRPF4B | 0.27710894 |
| 137 | KDR | 0.27420816 |
| 138 | PRKCZ | 0.27176119 |
| 139 | EPHB2 | 0.27154027 |
| 140 | TNK2 | 0.26893462 |
| 141 | MAPK3 | 0.26667473 |
| 142 | RAF1 | 0.25942578 |
| 143 | INSR | 0.25626103 |
| 144 | PRKCH | 0.24037123 |
| 145 | MAPK1 | 0.23918480 |
| 146 | BLK | 0.22108240 |
| 147 | CAMK2A | 0.21654768 |
| 148 | MAPK4 | 0.21604710 |
| 149 | RPS6KA3 | 0.21257698 |
| 150 | RPS6KB1 | 0.21219800 |
| 151 | STK10 | 0.20566520 |
| 152 | PRKACG | 0.20399051 |
| 153 | MAP3K9 | 0.19846421 |
| 154 | MARK2 | 0.19192839 |
| 155 | JAK1 | 0.18843269 |
| 156 | TBK1 | 0.18200212 |
| 157 | ALK | 0.17578765 |
| 158 | LATS1 | 0.16950532 |
| 159 | ABL1 | 0.16287206 |
| 160 | STK38 | 0.14524027 |
| 161 | RIPK4 | 0.14484590 |
| 162 | AKT2 | 0.14170785 |
| 163 | KIT | 0.14051991 |
| 164 | MAPKAPK2 | 0.12457091 |
| 165 | MAP3K7 | 0.11270566 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 4.66838386 |
| 2 | Platelet activation_Homo sapiens_hsa04611 | 4.29992819 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.90999854 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.75873531 |
| 5 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.54839775 |
| 6 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.49320018 |
| 7 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.40525977 |
| 8 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.19738002 |
| 9 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 2.18046022 |
| 10 | mTOR signaling pathway_Homo sapiens_hsa04150 | 2.03019200 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.00317915 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.97728557 |
| 13 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.97293611 |
| 14 | Circadian rhythm_Homo sapiens_hsa04710 | 1.92679107 |
| 15 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.92538916 |
| 16 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.86896440 |
| 17 | Base excision repair_Homo sapiens_hsa03410 | 1.81254909 |
| 18 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.77998376 |
| 19 | Adherens junction_Homo sapiens_hsa04520 | 1.74612120 |
| 20 | Lysine degradation_Homo sapiens_hsa00310 | 1.68073449 |
| 21 | Bile secretion_Homo sapiens_hsa04976 | 1.66317270 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.60693909 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.59385213 |
| 24 | Leishmaniasis_Homo sapiens_hsa05140 | 1.55371712 |
| 25 | Malaria_Homo sapiens_hsa05144 | 1.54639591 |
| 26 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.54142322 |
| 27 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.53240568 |
| 28 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.51098975 |
| 29 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.47321894 |
| 30 | Lysosome_Homo sapiens_hsa04142 | 1.47019238 |
| 31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.43348730 |
| 32 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.41974670 |
| 33 | ABC transporters_Homo sapiens_hsa02010 | 1.41141241 |
| 34 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.40961986 |
| 35 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.38485452 |
| 36 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.37883150 |
| 37 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.35972905 |
| 38 | Phagosome_Homo sapiens_hsa04145 | 1.33635951 |
| 39 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.33289142 |
| 40 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.33199180 |
| 41 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.30731601 |
| 42 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.30143610 |
| 43 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.29235624 |
| 44 | Tuberculosis_Homo sapiens_hsa05152 | 1.28438639 |
| 45 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.27974218 |
| 46 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.25929575 |
| 47 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.23745451 |
| 48 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.14145888 |
| 49 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.14118455 |
| 50 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.11244279 |
| 51 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.09845689 |
| 52 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.08608448 |
| 53 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.08189260 |
| 54 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.07940653 |
| 55 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.06627689 |
| 56 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.05883549 |
| 57 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.04525305 |
| 58 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.03555018 |
| 59 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.01942172 |
| 60 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.01862036 |
| 61 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.01055732 |
| 62 | Allograft rejection_Homo sapiens_hsa05330 | 1.00005078 |
| 63 | Asthma_Homo sapiens_hsa05310 | 0.99255360 |
| 64 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.98143316 |
| 65 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.96646036 |
| 66 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.95974882 |
| 67 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.95395868 |
| 68 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.95167988 |
| 69 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.94951884 |
| 70 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.91625472 |
| 71 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.91453767 |
| 72 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.90672369 |
| 73 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.89559316 |
| 74 | Salmonella infection_Homo sapiens_hsa05132 | 0.89109826 |
| 75 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.87762787 |
| 76 | Apoptosis_Homo sapiens_hsa04210 | 0.86472128 |
| 77 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.86452711 |
| 78 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.86376683 |
| 79 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.85568934 |
| 80 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.84726097 |
| 81 | Peroxisome_Homo sapiens_hsa04146 | 0.83297833 |
| 82 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.83285149 |
| 83 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.82393184 |
| 84 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.81715653 |
| 85 | Measles_Homo sapiens_hsa05162 | 0.80254324 |
| 86 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.79449265 |
| 87 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.79330769 |
| 88 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.79117697 |
| 89 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.78691177 |
| 90 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.77994077 |
| 91 | Endometrial cancer_Homo sapiens_hsa05213 | 0.77591290 |
| 92 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.77557214 |
| 93 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.77163431 |
| 94 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.76419332 |
| 95 | Amoebiasis_Homo sapiens_hsa05146 | 0.76308064 |
| 96 | Alcoholism_Homo sapiens_hsa05034 | 0.76102761 |
| 97 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.75469173 |
| 98 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.73374425 |
| 99 | Histidine metabolism_Homo sapiens_hsa00340 | 0.73208499 |
| 100 | Influenza A_Homo sapiens_hsa05164 | 0.73128657 |
| 101 | Shigellosis_Homo sapiens_hsa05131 | 0.72605893 |
| 102 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.72540801 |
| 103 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71415529 |
| 104 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.69907438 |
| 105 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.69139673 |
| 106 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.68677563 |
| 107 | Viral myocarditis_Homo sapiens_hsa05416 | 0.66810121 |
| 108 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.66612196 |
| 109 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.66073832 |
| 110 | Other glycan degradation_Homo sapiens_hsa00511 | 0.65957224 |
| 111 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.65088988 |
| 112 | Pertussis_Homo sapiens_hsa05133 | 0.64553225 |
| 113 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.63776085 |
| 114 | Hepatitis C_Homo sapiens_hsa05160 | 0.63313644 |
| 115 | Insulin resistance_Homo sapiens_hsa04931 | 0.63018624 |
| 116 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.62769439 |
| 117 | Hepatitis B_Homo sapiens_hsa05161 | 0.62579425 |
| 118 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.61943384 |
| 119 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.61880756 |
| 120 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.61220093 |
| 121 | Bladder cancer_Homo sapiens_hsa05219 | 0.61216684 |
| 122 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.60967363 |
| 123 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.60818829 |
| 124 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.60741407 |
| 125 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.60303822 |
| 126 | Mismatch repair_Homo sapiens_hsa03430 | 0.60146660 |
| 127 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.59891929 |
| 128 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.59734808 |
| 129 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.58869599 |
| 130 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.58178858 |
| 131 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.57151524 |
| 132 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56085648 |
| 133 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.56032075 |
| 134 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.55231115 |
| 135 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.54760673 |
| 136 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.54356377 |
| 137 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.53711457 |
| 138 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.53373609 |
| 139 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.53300722 |
| 140 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.53047353 |
| 141 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51859140 |
| 142 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.50947441 |
| 143 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50645465 |
| 144 | Long-term depression_Homo sapiens_hsa04730 | 0.49154087 |
| 145 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.49057133 |
| 146 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.48631422 |
| 147 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.47854811 |
| 148 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.46210112 |
| 149 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46044653 |
| 150 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.44908274 |
| 151 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.44833501 |
| 152 | Gap junction_Homo sapiens_hsa04540 | 0.44668842 |
| 153 | * Endocytosis_Homo sapiens_hsa04144 | 0.44525476 |
| 154 | Legionellosis_Homo sapiens_hsa05134 | 0.43866735 |
| 155 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.43448556 |
| 156 | Tight junction_Homo sapiens_hsa04530 | 0.41317035 |
| 157 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.39313609 |
| 158 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.38931994 |
| 159 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38727879 |
| 160 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.38323500 |
| 161 | Mineral absorption_Homo sapiens_hsa04978 | 0.37001801 |
| 162 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36944642 |
| 163 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.36379440 |
| 164 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.36170484 |
| 165 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.36014430 |
| 166 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.35320948 |
| 167 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.34408835 |
| 168 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.34408153 |
| 169 | Carbon metabolism_Homo sapiens_hsa01200 | 0.34204698 |
| 170 | Focal adhesion_Homo sapiens_hsa04510 | 0.33269900 |
| 171 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.32653579 |

